Zobrazeno 1 - 10
of 64
pro vyhledávání: '"Matthew A Spinelli"'
Autor:
Matthew S. Durstenfeld, Michael J. Peluso, Matthew A. Spinelli, Danny Li, Rebecca Hoh, Ahmed Chenna, Brandon Yee, John Winslow, Christos Petropoulos, Monica Gandhi, Timothy J. Henrich, Mandar A. Aras, Carlin S. Long, Steven G. Deeks, Priscilla Y. Hsue
Publikováno v:
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, Vol 12, Iss 20 (2023)
Background Postacute sequelae of COVID‐19 (PASC) and HIV are both associated with reduced exercise capacity, but whether SARS‐CoV‐2 or PASC are associated with exercise capacity among people with HIV (PWH) is unknown. We hypothesized that PWH w
Externí odkaz:
https://doaj.org/article/941776a87cf343a595f055b28175ecbf
Autor:
Michael J. Peluso, Tyler-Marie Deveau, Sadie E. Munter, Dylan Ryder, Amanda Buck, Gabriele Beck-Engeser, Fay Chan, Scott Lu, Sarah A. Goldberg, Rebecca Hoh, Viva Tai, Leonel Torres, Nikita S. Iyer, Monika Deswal, Lynn H. Ngo, Melissa Buitrago, Antonio Rodriguez, Jessica Y. Chen, Brandon C. Yee, Ahmed Chenna, John W. Winslow, Christos J. Petropoulos, Amelia N. Deitchman, Joanna Hellmuth, Matthew A. Spinelli, Matthew S. Durstenfeld, Priscilla Y. Hsue, J. Daniel Kelly, Jeffrey N. Martin, Steven G. Deeks, Peter W. Hunt, Timothy J. Henrich
Publikováno v:
The Journal of Clinical Investigation, Vol 133, Iss 3 (2023)
BACKGROUND The presence and reactivation of chronic viral infections, such as EBV, CMV, and HIV, have been proposed as potential contributors to long COVID (LC), but studies in well-characterized postacute cohorts of individuals with COVID-19 over a
Externí odkaz:
https://doaj.org/article/412cbc831bfe489a8055fa7ce7beae94
Autor:
Michael J. Peluso, Amelia N. Deitchman, Leonel Torres, Nikita S. Iyer, Sadie E. Munter, Christopher C. Nixon, Joanna Donatelli, Cassandra Thanh, Saki Takahashi, Jill Hakim, Keirstinne Turcios, Owen Janson, Rebecca Hoh, Viva Tai, Yanel Hernandez, Emily A. Fehrman, Matthew A. Spinelli, Monica Gandhi, Lan Trinh, Terri Wrin, Christos J. Petropoulos, Francesca T. Aweeka, Isabel Rodriguez-Barraquer, J. Daniel Kelly, Jeffrey N. Martin, Steven G. Deeks, Bryan Greenhouse, Rachel L. Rutishauser, Timothy J. Henrich
Publikováno v:
Cell Reports, Vol 36, Iss 6, Pp 109518- (2021)
Summary: We describe severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)-specific T cell responses, soluble markers of inflammation, and antibody levels and neutralization capacity longitudinally in 70 individuals with PCR-confirmed SARS-CoV
Externí odkaz:
https://doaj.org/article/3c9c02e0fee544eb9764cc9e8b79dffd
Autor:
Suzanne M. McCluskey, Katya Govender, John Adamson, Monica Gandhi, Matthew A. Spinelli, Mahomed-Yunus Moosa, Winnie Muyindike, Pravi Moodley, Melendhran Pillay, Godfrey Masette, Henry Sunpath, Selvan Pillay, Geoffrey Chen, Bethany Hedt-Gauthier, Vincent C. Marconi, Mark J. Siedner
Publikováno v:
AIDS. 37:1109-1113
Publikováno v:
Current HIV/AIDS Reports. 19:425-432
In this review, we examine the intersection of the HIV and COVID-19 epidemics with focus on COVID-19-related health outcomes and risk factors for SARS-CoV-2 among people living with HIV (PLWH).Evidence to date do not suggest a higher incidence of SAR
Autor:
Michael J, Peluso, Matthew A, Spinelli, Tyler-Marie, Deveau, Carrie A, Forman, Sadie E, Munter, Sujata, Mathur, Alex F, Tang, Scott, Lu, Sarah A, Goldberg, Mireya I, Arreguin, Rebecca, Hoh, Viva, Tai, Jessica Y, Chen, Enrique O, Martinez, Brandon C, Yee, Ahmed, Chenna, John W, Winslow, Christos J, Petropoulos, Alessandro, Sette, Daniella, Weiskopf, Nitasha, Kumar, Kara L, Lynch, Peter W, Hunt, Matthew S, Durstenfeld, Priscilla Y, Hsue, J Daniel, Kelly, Jeffrey N, Martin, David V, Glidden, Monica, Gandhi, Steven G, Deeks, Rachel L, Rutishauser, Timothy J, Henrich
Publikováno v:
AIDS. 36:F7-F16
Limited data are available on the long-term clinical and immunologic consequences of SARS-CoV-2 infection in people with HIV (PWH).We measured SARS-CoV-2-specific humoral and cellular responses in people with and without HIV recovering from COVID-19
Autor:
Tracy Kellermann, Monica Gandhi, Eric H Decloedt, Gert U. van Zyl, Matthew A Spinelli, Zukiswa Nkantsu, Marije van Schalkwyk, Dolphina Cogill, Catherine Orrell, Lauren Jennings
Publikováno v:
AIDS Res Hum Retroviruses
Introduction The high cost of viral load (VL) testing limits its use for antiretroviral treatment (ART) adherence support. A low-cost lateral flow urine tenofovir (TFV) rapid assay predicts PrEP breakthroughs but has not yet been investigated in HIV
Autor:
Matthew A Spinelli, Noelle Le Tourneau, David V Glidden, Ling Hsu, Matthew D Hickey, Elizabeth Imbert, Mireya Arreguin, Jennifer P Jain, Jon J Oskarsson, Susan P Buchbinder, Mallory O Johnson, Diane Havlir, Katerina A Christopoulos, Monica Gandhi
Publikováno v:
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, vol 75, iss 1
Background After coronavirus disease 2019 (COVID-19) shelter-in-place (SIP) orders, viral suppression (VS) rates initially decreased within a safety-net human immunodeficiency virus (HIV) clinic in San Francisco, particularly among people living with
Autor:
Michael J, Peluso, Tyler-Marie, Deveau, Sadie E, Munter, Dylan, Ryder, Amanda, Buck, Gabriele, Beck-Engeser, Fay, Chan, Scott, Lu, Sarah A, Goldberg, Rebecca, Hoh, Viva, Tai, Leonel, Torres, Nikita S, Iyer, Monika, Deswal, Lynn H, Ngo, Melissa, Buitrago, Antonio, Rodriguez, Jessica Y, Chen, Brandon C, Yee, Ahmed, Chenna, John W, Winslow, Christos J, Petropoulos, Amelia N, Deitchman, Joanna, Hellmuth, Matthew A, Spinelli, Matthew S, Durstenfeld, Priscilla Y, Hsue, J Daniel, Kelly, Jeffrey N, Martin, Steven G, Deeks, Peter W, Hunt, Timothy J, Henrich
Publikováno v:
The Journal of clinical investigation.
The presence and reactivation of chronic viral infections such as Epstein-Barr virus (EBV), cytomegalovirus (CMV) and human immunodeficiency virus (HIV) have been proposed as potential contributors to Long COVID (LC), but studies in well-characterize
Publikováno v:
J Acquir Immune Defic Syndr
Journal of acquired immune deficiency syndromes (1999), vol 88, iss 1
Journal of acquired immune deficiency syndromes (1999), vol 88, iss 1
BACKGROUND Tenofovir alafenamide (TAF) is increasingly used in HIV treatment, with or without agents that require pharmacologic boosters such as ritonavir/cobicistat. Boosters increase TAF levels, so the TAF dose is lowered in single-pill combination